title: Should we offer famciclovir to patients with new-onset herpes zoster?
authors.affiliation: Kildonan Medical Centres, Winnipeg, Man.
authors.forename: F
authors.initials: F
authors.lastname: Martin
authors.forename: M F
authors.initials: MF
authors.lastname: Evans
mesh_terms: D015075:2-Aminopurine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000208:Acute Disease; D000367:Age Factors; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D000077595:Famciclovir; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D011355:Prodrugs; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D010919:Placebos; D011355:Prodrugs; D015075:2-Aminopurine; D000077595:Famciclovir